Infection is the second leading cause of death in patients with chronic kidney disease (CKD).
Adequate humoral (antibody) and cellular (T cell-driven) immunity are required to minimize …

Chronic kidney disease (CKD) patients are at high risk for infectious complications. This is
partly due to their dysfunctional immune system, especially in advanced CKD stages …

The following chapter is focused on the impact of comorbidities on the effectiveness of
vaccination in older persons. Relevant comorbidities are cardiovascular diseases like …

Cytokines are regulators of the immune response against severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2). However, the contribution of cytokine-secreting …

Introduction Vaccination is the effective strategy for coronavirus disease 2019 (COVID‐19).
However, few studies have investigated the association between severe acute respiratory …

This study analyzed binding and neutralizing antibody titers up to 6 months after standard
vaccination with BNT162b2 (two doses of 30 µg each) in SARS-CoV-2 naïve patients (n …

(1) Background: Chronic inflammation and suboptimal immune responses to vaccinations
are considered to be aspects of immune dysregulation in patients that are undergoing …

Hepatitis B vaccination is recommended in all patients with end-stage kidney disease
(ESKD). However, only 50–60% of these patients achieve protective antibody levels if …

Aim: This scoping review aims to identify and map the extent of published literature on
Hepatitis B vaccination in stage 4/5 chronic kidney disease (CKD) and dialysis patients, the …

Background and aims The effects of influenza vaccination (IV) on the outcomes of patients
with kidney disease (KD) are not completely understood. We aimed to evaluate and …